VYBRIQUE is a sildenafil oral film formulated for discreet, water-free administration, aiming to reduce use barriers for patients for whom privacy and convenience influence ED treatment adherence. A ...

A popular honey product has been voluntarily recalled by its manufacturer, Akkarco, after the U.S. Food and Drug Administration (FDA) notified the company that samples of the product contained an ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

A new drug for erectile dysfunction is being studied. It targets the nervous system for longer-lasting relief than current ED medications. Experts warn against unregulated online drugs and advise ...

Erectile dysfunction (ED), a common and highly treatable condition, affects millions of men, many starting to have symptoms in middle age. A new drug is being investigated to help those who don’t find ...

How to Do It is Slate’s sex advice column. Have a question? Send it to Stoya and Rich here. It’s anonymous! Dear How to Do It, My husband and I went over to his parents’ for the Christmas holiday. His ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Let’s cut to the chase: erectile dysfunction (ED) ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. During the pandemic, I did what many ...

ExtenZe has not been proven to work for erectile dysfunction. Many of ExtenZe's ingredients have no safety or effectiveness studies in humans. The company behind ExtenZe was fined for false ...

Simultaneous stress urinary incontinence (SUI) and erectile dysfunction (ED) are commonly caused by prostate surgery. Penile prosthesis is the gold standard for erectile dysfunction refractory to ...

Sexual dysfunction post-cancer treatment is underdiscussed, impacting patient and partner quality of life significantly. The EU-ProPER study reveals partners often lack information on treatment ...